Company Overview
- Headquarters
- 1020 East Meadow Circle, Palo Alto CA
- Website
- anacor.com
- Phone
- (650) 543-****
- Employees
- 42
- Founded in
- 2002
- Industry
- Materials/Manufacturing
- NAICS Code
- 3254, 5417, 32, 541, 54, 32541, 325
- SIC Code
- 283, 28
Financials & Stats
Revenue
$82B
Total Funding Amount
$466M
Who is Anacor Pharmaceuticals
Anacor Pharmaceuticals was a biopharmaceutical company headquartered in Palo Alto, California. Founded in 1998, the company employed 42 individuals. Anacor focused on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Their product pipeline included five clinical compounds, targeting various dermatological and infectious diseases. Their lead programs included AN2690, a topical antifungal for treating onychomycosis; AN2728, a topical anti-inflammatory PDE-4 inhibitor for psoriasis; and GSK 2251052, a systemic antibiotic for treating infections caused by Gram-negative bacteria, licensed to GlaxoSmithKline. Additionally, Anacor developed AN2718, a topical antifungal for treating onychomycosis and skin fungal infections, and AN2898, a topical anti-inflammatory for psoriasis and atopic dermatitis. One of Anacor's key differentiators was its proprietary boron chemistry platform, enabling the development of innovative therapeutic solutions. Interested parties can visit Anacor Pharmaceuticals' website at anacor.com for further information.
Anacor Pharmaceuticals Tech Stack
Companies Similar to Anacor Pharmaceuticals
Analyze industry trends and opportunities by examining competitors and companies comparable to Anacor Pharmaceuticals, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 82M | 11 | Leon, TX | 2008 | |
| 82M | 403 | Bountiful, UT | 1986 | |
| 82M | 362 | Troy, MI | 1926 | |
| 80M | 75 | Los Angeles, CA | 2014 | |
| 80M | 65 | Berkeley, IL | 2008 |